Method of treating osteoporosis comprising administration of PTHrP analog
US7803770B2 · kind B2 · utility
26Cited by
20References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 9, 2008 |
| Grant date | Sep 28, 2010 |
| Priority date | — |
| Expiry date | Oct 31, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) and methods of using a PTHrP and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.